AIN vs BABA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant deterioration in core profitability and earnings quality. Despite a reasonable current ratio and moderate debt/equity, the company is reporting negative profit and operating margins (-4.66% and -43.73% respectively), alongside a year-over-year revenue decline of 12.40%, which severely undermines its valuation. Although the stock trades below its 52-week high and has a modest dividend yield of 1.93%, the technical trend is deeply bearish (0/100), and analyst consensus is a hold with a target price below current levels. The combination of deteriorating fundamentals, poor earnings predictability, and lackluster price performance over the past three years supports a bearish outlook.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.